Literature DB >> 33231258

Comparison of predictive performance for toxicity by accumulative dose of DVH parameter addition and DIR addition for cervical cancer patients.

Yuya Miyasaka1,2, Noriyuki Kadoya1, Rei Umezawa1, Yoshiki Takayama1,3, Kengo Ito1, Takaya Yamamoto1, Shohei Tanaka1, Suguru Dobashi4, Ken Takeda4, Kenji Nemoto5, Takeo Iwai2, Keiichi Jingu1.   

Abstract

We compared predictive performance between dose volume histogram (DVH) parameter addition and deformable image registration (DIR) addition for gastrointestinal (GI) toxicity in cervical cancer patients. A total of 59 patients receiving brachytherapy and external beam radiotherapy were analyzed retrospectively. The accumulative dose was calculated by three methods: conventional DVH parameter addition, full DIR addition and partial DIR addition. ${D}_{2{cm}^3}$, ${D}_{1{cm}^3}$ and ${D}_{0.1{cm}^3}$ (minimum doses to the most exposed 2 cm3, 1cm3 and 0.1 cm3 of tissue, respectively) of the rectum and sigmoid were calculated by each method. V50, V60 and V70 Gy (volume irradiated over 50, 60 and 70 Gy, respectively) were calculated in full DIR addition. The DVH parameters were compared between toxicity (≥grade1) and non-toxicity groups. The area under the curve (AUC) of the receiver operating characteristic (ROC) curves were compared to evaluate the predictive performance of each method. The differences between toxicity and non-toxicity groups in ${D}_{2{cm}^3}$ were 0.2, 5.7 and 3.1 Gy for the DVH parameter addition, full DIR addition and partial DIR addition, respectively. The AUCs of ${D}_{2{cm}^3}$ were 0.51, 0.67 and 0.57 for DVH parameter addition, full DIR addition and partial DIR addition, respectively. In full DIR addition, the difference in dose between toxicity and non-toxicity was the largest and AUC was the highest. AUCs of V50, V60 and V70 Gy were 0.51, 0.63 and 0.62, respectively, and V60 and V70 were high values close to the value of ${D}_{2{cm}^3}$ of the full DIR addition. Our results suggested that the full DIR addition may have the potential to predict toxicity more accurately than the conventional DVH parameter addition, and that it could be more effective to accumulate to all pelvic irradiation by DIR.
© The Author(s) 2020. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology.

Entities:  

Keywords:  GI toxicity; brachytherapy; cervical cancer; deformable image registration; dose accumulation

Year:  2021        PMID: 33231258      PMCID: PMC7779363          DOI: 10.1093/jrr/rraa099

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  30 in total

1.  Dosimetric variations due to interfraction organ deformation in cervical cancer brachytherapy.

Authors:  Kazuma Kobayashi; Naoya Murakami; Akihisa Wakita; Satoshi Nakamura; Hiroyuki Okamoto; Rei Umezawa; Kana Takahashi; Koji Inaba; Hiroshi Igaki; Yoshinori Ito; Naoyuki Shigematsu; Jun Itami
Journal:  Radiother Oncol       Date:  2015-08-24       Impact factor: 6.280

2.  Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.

Authors:  Richard Pötter; Christine Haie-Meder; Erik Van Limbergen; Isabelle Barillot; Marisol De Brabandere; Johannes Dimopoulos; Isabelle Dumas; Beth Erickson; Stefan Lang; An Nulens; Peter Petrow; Jason Rownd; Christian Kirisits
Journal:  Radiother Oncol       Date:  2006-01-05       Impact factor: 6.280

3.  The ANACONDA algorithm for deformable image registration in radiotherapy.

Authors:  Ola Weistrand; Stina Svensson
Journal:  Med Phys       Date:  2015-01       Impact factor: 4.071

4.  Evaluation of deformable image registration between external beam radiotherapy and HDR brachytherapy for cervical cancer with a 3D-printed deformable pelvis phantom.

Authors:  Noriyuki Kadoya; Yuya Miyasaka; Yujiro Nakajima; Yoshihiro Kuroda; Kengo Ito; Mizuki Chiba; Kiyokazu Sato; Suguru Dobashi; Takaya Yamamoto; Noriyoshi Takahashi; Masaki Kubozono; Ken Takeda; Keiichi Jingu
Journal:  Med Phys       Date:  2017-04       Impact factor: 4.071

5.  Simple DVH parameter addition as compared to deformable registration for bladder dose accumulation in cervix cancer brachytherapy.

Authors:  Else Stougård Andersen; Karsten Østergaard Noe; Thomas Sangild Sørensen; Søren Kynde Nielsen; Lars Fokdal; Merete Paludan; Jacob Christian Lindegaard; Kari Tanderup
Journal:  Radiother Oncol       Date:  2013-03-13       Impact factor: 6.280

6.  Bladder accumulated dose in image-guided high-dose-rate brachytherapy for locally advanced cervical cancer and its relation to urinary toxicity.

Authors:  Roja Zakariaee; Ghassan Hamarneh; Colin J Brown; Marc Gaudet; Christina Aquino-Parsons; Ingrid Spadinger
Journal:  Phys Med Biol       Date:  2016-11-15       Impact factor: 3.609

Review 7.  Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.

Authors:  Christine Haie-Meder; Richard Pötter; Erik Van Limbergen; Edith Briot; Marisol De Brabandere; Johannes Dimopoulos; Isabelle Dumas; Taran Paulsen Hellebust; Christian Kirisits; Stefan Lang; Sabine Muschitz; Juliana Nevinson; An Nulens; Peter Petrow; Natascha Wachter-Gerstner
Journal:  Radiother Oncol       Date:  2005-03       Impact factor: 6.280

8.  Concurrent weekly nedaplatin, external beam radiotherapy and high-dose-rate brachytherapy in patients with FIGO stage IIIb cervical cancer: a comparison with a cohort treated by radiotherapy alone.

Authors:  Seiji Mabuchi; Hiromi Ugaki; Fumiaki Isohashi; Yasuo Yoshioka; Kumiko Temma; Namiko Yada-Hashimoto; Takashi Takeda; Toshiya Yamamoto; Kiyoshi Yoshino; Ryuichi Nakajima; Chie Kuragaki; Kenichirou Morishige; Takayuki Enomoto; Takehiro Inoue; Tadashi Kimura
Journal:  Gynecol Obstet Invest       Date:  2010-01-07       Impact factor: 2.031

9.  Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study.

Authors:  Lars Fokdal; Alina Sturdza; Renaud Mazeron; Christine Haie-Meder; Li Tee Tan; Charles Gillham; Barbara Šegedin; Ina Jürgenliemk-Schultz; Christian Kirisits; Peter Hoskin; Richard Pötter; Jacob C Lindegaard; Kari Tanderup
Journal:  Radiother Oncol       Date:  2016-04-21       Impact factor: 6.280

10.  Assessing cumulative dose distributions in combined radiotherapy for cervical cancer using deformable image registration with pre-imaging preparations.

Authors:  Takanori Abe; Tomoaki Tamaki; Souichi Makino; Takeshi Ebara; Ryuuta Hirai; Kazunori Miyaura; Yu Kumazaki; Tatsuya Ohno; Naoto Shikama; Takashi Nakano; Shingo Kato
Journal:  Radiat Oncol       Date:  2014-12-20       Impact factor: 3.481

View more
  1 in total

1.  A model to guide the management and decision of re-planning during radiotherapy for cervical cancer.

Authors:  Wei Zhang; Xiuhua Li; Tingting Lin; Fang Ma; Xiaoyu Ma; Xiaoli Wu; Yingming Sun; Xiaoge Sun
Journal:  Transl Cancer Res       Date:  2021-12       Impact factor: 1.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.